Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Benzinga · 07/26/2024 09:57
Shares of Ultra Clean Holdings, Inc. (NASDAQ:UCTT) shares surged 17.4% to $53.00 in pre-market trading following better-than-expected quarterly results.
Ultra Clean reported quarterly earnings of 32 cents per share which beat the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $516.100 million which beat the analyst consensus estimate of $490.064 million, according to data from Benzinga Pro.
Ultra Clean shares jumped 17.4% to $53.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Windtree Therapeutics, Inc. (NASDAQ:WINT) rose 110.3% to $6.94 in pre-market trading. Windtree Therapeutics filed Form RW to withdraw registration statement on Form S-1.
- BurgerFi International, Inc. (NASDAQ:BFI) gained 83% to $0.39 in pre-market trading after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.
- Carbon Revolution Public Limited Company (NASDAQ:CREV) shares climbed 30.6% to $8.06 in pre-market trading. Carbon Revolution said it will supply the carbon fiber wheels available on the just-revealed Chevrolet Corvette ZR1.
- Coursera, Inc. (NYSE:COUR) shares gained 24.7% to $9.24 in pre-market trading after the company beat second-quarter earnings estimates.
- Zapata Computing Holdings Inc. (NASDAQ:ZPTA) gained 24.5% to $0.6720 in pre-market trading.
- Selina Hospitality PLC (NASDAQ:SLNA) shares gained 23.7% to $0.0465 in pre-market trading after falling over 17% on Thursday.
- Mohawk Industries, Inc. (NYSE:MHK) gained 11.5% to $150.00 in pre-market trading following mixed second-quarter earnings.
- Deckers Outdoor Corporation (NYSE:DECK) shares gained 11.2% to $935.45 in pre-market trading as the company reported better-than-expected results for the first quarter. The company said it still expects net sales to increase approximately 10% year-over-year in fiscal year 2025 to $4.7 billion.
- Karooooo Ltd (NASDAQ:KARO) gained 9.4% to $31.50 in pre-market trading. Karooooo announced termination of secondary public offering of ordinary shares due to market conditions.
Losers
- NovaBay Pharmaceuticals, Inc. (NYSE:NBY) shares fell 40.7% to $1.15 in pre-market trading after dipping 10% on Thursday.
- DexCom, Inc. (NASDAQ:DXCM) shares declined 37% to $68.00 in pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.
- Advent Technologies Holdings, Inc. (NASDAQ:ADN) shares fell 35.2% to $3.21 in pre-market trading after gaining 3% on Thursday.
- Nature’s Miracle Holding Inc. (NASDAQ:NMHI) shares fell 31.2% to $0.2696 in pre-market trading after declining around 9% on Thursday.
- Ocean Power Technologies, Inc. (NASDAQ:OPTT) shares declined 21.7% to $0.3250 in pre-market trading after reporting fourth-quarter results.
- Zynex, Inc. (NASDAQ:ZYXI) shares fell 21.5% to $8.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results.
- Exicure, Inc. (NASDAQ:XCUR) fell 16.4% to $0.4181 in pre-market trading after gaining around 25% on Thursday.
- Conn’s, Inc. (NASDAQ:CONN) fell 13.7% to $0.3528 in pre-market trading after surging 17% on Thursday.
- Ur-Energy Inc. (NYSE:URG) shares dipped 9.2% to $1.18 in pre-market trading after the company announced a proposed public offering of common shares.
- Tandem Diabetes Care, Inc. (NASDAQ:TNDM) shares fell 9% to $36.99 in pre-market trading. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.
Now Read This:
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.